Legal & General Group Plc - AIMMUNE THERAPEUTICS INC ownership

AIMMUNE THERAPEUTICS INC's ticker is AIMT and the CUSIP is 00900T107. A total of 161 filers reported holding AIMMUNE THERAPEUTICS INC in Q1 2020. The put-call ratio across all filers is 0.95 and the average weighting 0.1%.

Quarter-by-quarter ownership
Legal & General Group Plc ownership history of AIMMUNE THERAPEUTICS INC
ValueSharesWeighting
Q3 2020$980,000
+92.5%
28,450
-6.6%
0.00%
Q2 2020$509,000
+17.3%
30,467
+1.3%
0.00%
Q1 2020$434,000
-59.7%
30,066
-6.6%
0.00%
-100.0%
Q4 2019$1,077,000
+163.3%
32,180
+64.6%
0.00%
Q3 2019$409,000
+0.5%
19,5500.0%0.00%
Q2 2019$407,000
-1.5%
19,550
+5.8%
0.00%
Q1 2019$413,000
-5.5%
18,481
+1.1%
0.00%
Q4 2018$437,000
+13.2%
18,273
+29.1%
0.00%
Q3 2018$386,000
+1.3%
14,1500.0%0.00%
Q2 2018$381,000
-15.1%
14,150
+0.3%
0.00%
Q1 2018$449,000
+29.8%
14,102
+55.2%
0.00%
Q4 2017$346,000
+56.6%
9,087
+1.5%
0.00%
Q3 2017$221,000
+38.1%
8,955
+15.2%
0.00%
Q2 2017$160,000
+19.4%
7,776
+26.6%
0.00%
Q1 2017$134,000
+4.7%
6,142
-1.5%
0.00%
Q4 2016$128,000
+137.0%
6,238
+66.4%
0.00%
Q3 2016$54,000
-41.3%
3,749
-54.7%
0.00%
Q2 2016$92,0008,2760.00%
Other shareholders
AIMMUNE THERAPEUTICS INC shareholders Q1 2020
NameSharesValueWeighting ↓
Aisling Capital LLC 1,240,000$25,966,00057.34%
Foresite Capital Management II, LLC 2,605,499$54,559,00011.53%
Foresite Capital Management III, LLC 611,893$12,813,0004.89%
Palo Alto Investors LP 3,471,740$72,698,0004.84%
SANDERS MORRIS HARRIS LLC 486,906$10,196,0002.47%
Eventide Asset Management 3,084,000$64,579,0002.13%
Sofinnova Investments, Inc. 346,770$7,261,0000.66%
EMERALD ADVISERS, LLC 610,511$12,784,0000.60%
RICE HALL JAMES & ASSOCIATES, LLC 752,358$15,754,0000.56%
EMERALD MUTUAL FUND ADVISERS TRUST 587,464$12,301,0000.54%
View complete list of AIMMUNE THERAPEUTICS INC shareholders